Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Lactibiane Candisis 5M
- Development stage
- Discontinued
- Lead developer
- PiLeJe
- Modality
- Yeast Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Bacterial Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Defined Consortia → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Complex Communities → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics
- Administration
- Oral
01
Overview
Lactibiane Candisis 5M is an oral PiLeJe probiotic dietary supplement containing the microbiotic strain *Lactobacillus helveticus* LA401 candisis at 5 billion CFU per capsule. It was studied as an adjunct after local econazole therapy for prevention of recurrent vulvovaginal candidiasis; the registered clinical trial was terminated. The product is intended to support intestinal and vaginal microbiota balance rather than act as a conventional antifungal pharmaceutical. ([clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00915629))
- Brand names
- Lactibiane Candisis 5MLactibiane CND 5M
- Other names
- Lactibiane Candisis
Beyond the preview
Go deeper on Lactibiane Candisis 5M.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Lactibiane Candisis 5M.